INTERACTIONS OF PHENOBARBITAL AND PHENYTOIN WITH CARBAMAZEPINE AND ITS METABOLITES CONCENTRATIONS, CONCENTRATION RATIOS, AND LEVEL DOSE RATIOS IN EPILEPTIC CHILDREN

被引:16
作者
LIU, H
DELGADO, MR
机构
[1] TEXAS SCOTTISH RITE HOSP CHILDREN,DEPT NEUROL,DALLAS,TX 75219
[2] UNIV TEXAS,SW MED CTR,DALLAS,TX
关键词
CARBAMAZEPINE; PHENYTOIN; PHENOBARBITAL; DRUG INTERACTION; EPILEPTIC CHILDREN;
D O I
10.1111/j.1528-1157.1995.tb00992.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effects of phenytoin (PHT) or phenobarbital (PB) comedication on the concentrations, concentration ratios, and level/dose ratios of carbamazepine (CBZ) and its metabolites were investigated. The heteroinduction effects of CBZ metabolism by PHT or PB were clearly demonstrated. Serum CBZ level/dose ratios in patients with CBZ polytherapy were decreased while CBZ-10,11-epoxide (CBZ-E) and trans-10,11-dihydroxy-10,11-dihydro-CBZ (CBZ-H) concentrations were increased as compared with those of patients receiving CBZ alone. The concentration ratios of CBZ-H/CBZ and CBZ-E/ CBZ were also greater in patients receiving CBZ + PHT or CBZ+PB than in patients receiving CBZ alone. In addition, positive correlations between serum PHT concentration and CBZ-H/CBZ or CBZ-E/CBZ concentration ratios were observed. There were no significant differences in CBZ-H/CBZ-E concentration ratios, the free fractions of CBZ and its metabolites, and CBZ-E or CBZ-H level/dose ratios among the three groups of patients. Because this approach investigates the in vivo relation between the substrates and products of the enzymes involved in CBZ biotransformation, more detailed information about the drug interactions was obtained. The results suggest that the PHT has a potent induction effect an CBZ epoxidase, whereas PB is a moderate inducer.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 25 条
[1]   CLINICAL PHARMACOKINETICS AND PHARMACOLOGICAL EFFECTS OF CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE - AN UPDATE [J].
BERTILSSON, L ;
TOMSON, T .
CLINICAL PHARMACOKINETICS, 1986, 11 (03) :177-198
[2]  
BOURGEOIS BFD, 1984, THER DRUG MONIT, V6, P259, DOI 10.1097/00007691-198409000-00001
[3]   PROBLEMS OF COMBINATION-DRUG THERAPY IN CHILDREN [J].
BOURGEOIS, BFD .
EPILEPSIA, 1988, 29 :S20-S24
[4]   CARBAMAZEPINE 10, 11 EPOXIDE CONCENTRATIONS IN EPILEPTICS ON CARBAMAZEPINE ALONE AND IN COMBINATION WITH OTHER ANTI-CONVULSANTS [J].
BRODIE, MJ ;
FORREST, G ;
RAPEPORT, WG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) :747-750
[5]   UNMASKING THE SIGNIFICANT ENZYME-INDUCING EFFECTS OF PHENYTOIN ON SERUM CARBAMAZEPINE CONCENTRATIONS DURING PHENYTOIN WITHDRAWAL [J].
CHAPRON, DJ ;
LAPIERRE, BA ;
ABOUELKAIR, M .
ANNALS OF PHARMACOTHERAPY, 1993, 27 (06) :708-711
[6]  
CHRISTIANSEN J, 1973, ACTA NEUROL SCAND, V47, P543
[7]  
EICHELBAUM M, 1979, CLIN PHARMACOL THER, V26, P366
[8]   FACTORS INFLUENCING SIMULTANEOUS CONCENTRATIONS OF TOTAL AND FREE CARBAMAZEPINE AND CARBAMAZEPINE-10, 11-EPOXIDE IN SERUM OF CHILDREN WITH EPILEPSY [J].
ELYAS, AA ;
PATSALOS, PN ;
AGBATO, OA ;
BRETT, EM ;
LASCELLES, PT .
THERAPEUTIC DRUG MONITORING, 1986, 8 (03) :288-292
[9]  
Faigle JW, 1989, ANTIEPILEPTIC DRUGS, P491
[10]  
HAIDUKEWYCH D, 1989, THER DRUG MONIT, V11, P528